top of page

Therapy for Patients with Previously Treated Metastatic Colorectal Cancer (mCRC)


INDICATION

STIVARGA is indicated for the treatment of patients with mCRC who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.


AUGUST 5th @7PM


Don't miss this virtual event!





8 views0 comments
bottom of page